Stockreport

Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights [Yahoo! Finance]

Whitehawk Therapeutics, Inc.  (WHWK) 
PDF HWK-206 on track for planned IND submission in mid-2026 and Phase 1 start in Q3 Cash, cash equivalents and short-term investments balance of $145.7M at YE2025, antici [Read more]